冠状动脉钙化积分与验前概率作为门控预测并排除正电子发射断层显像灌注缺损
研究纳入2050例无已知冠心病受试者,比较冠状动脉钙化积分(CACS)与美国心脏协会/美国心脏病学会(AHA/ACC)及欧洲心脏病学会(ESC)指南验前概率对心肌灌注正电子发射断层显像(PET)异常灌注的预测价值。CACS和验后概率预测异常灌注的曲线下面积(AUC)优于各自验前概率,CACS=0及验后概率≤5%具有很高阴性预测值。
要点
- CACS预测异常灌注的AUC为0.81,优于AHA/ACC验前概率0.68和ESC验前概率0.69。
- CACS=0的阴性预测值为97%,验后AHA/ACC≤5%为98%,验后ESC≤5%为96%。
- 验后概率≤5%的参与者比例(AHA/ACC 23%、ESC 33%)高于验前概率≤5%(2%、7%)。
核心结论
- CACS和验后概率能极好地预测异常灌注,并在相当比例参与者中以很高阴性预测值排除异常灌注。
- CACS和验后概率可作为先进影像检查前的门控工具。
研究设计与样本
- 研究纳入2050例无已知冠状动脉疾病、接受CACS和铷-82 PET的参与者,男54%,平均年龄64.6岁。
- 异常灌注定义为负荷总评分(SSS)≥4。
- 使用贝叶斯公式将验前概率与CACS合并为验后概率。
主要发现
- CACS中位数62(IQR 0-380),ESC验前概率中位数17%(11-26),AHA/ACC验前概率中位数27%(16-44),437例(21%)存在异常灌注。
- 预测异常灌注的AUC:CACS 0.81,AHA/ACC验前概率0.68,ESC验前概率0.69,AHA/ACC验后概率0.80,ESC验后概率0.81(CACS vs 各验前概率、各验后概率 vs 验前概率的P均<0.001)。
- 阴性预测值:CACS=0为97%,AHA/ACC验前概率≤5%为100%,ESC验前概率≤5%为98%,AHA/ACC验后概率≤5%为98%,ESC验后概率≤5%为96%。
- 参与者中CACS=0占26%,AHA/ACC验前概率≤5%占2%,ESC验前概率≤5%占7%,AHA/ACC验后概率≤5%占23%,ESC验后概率≤5%占33%(所有P<0.001)。
关键数值与推荐
- CACS=0的阴性预测值为97%。
- AHA/ACC验前概率≤5%的阴性预测值为100%,ESC验前概率≤5%为98%。
- AHA/ACC验后概率≤5%的阴性预测值为98%,ESC验后概率≤5%为96%。
临床怎么用
- CACS和验后概率可在先进影像检查前用于门控,以排除异常灌注。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Little is known about the gatekeeper performance of coronary artery calcium score (CACS) before myocardial perfusion positron emission tomography (PET), compared with updated pre-test probabilities from American and European guidelines (pre-test-AHA/ACC, pre-test-ESC). METHODS: We enrolled participants without known coronary artery disease undergoing CACS and Rubidium-82 PET. Abnormal perfusion was defined as summed stress score ≥ 4. Using Bayes' formula, pre-test probabilities and CACS were combined into post-test probabilities. RESULTS: We included 2050 participants (54% male, mean age 64.6 years) with median CACS 62 (IQR 0-380), pre-test-ESC 17% (11-26), pre-test-AHA/ACC 27% (16-44), and abnormal perfusion in 437 participants (21%). To predict abnormal perfusion, area under the curve of CACS was 0.81, pre-test-AHA/ACC 0.68, pre-test-ESC 0.69, post-test-AHA/ACC 0.80, and post-test-ESC 0.81 (P < 0.001 for CACS vs. each pre-test, and each post-test vs. pre-test). CACS = 0 had 97% negative predictive value (NPV), pre-test-AHA/ACC ≤ 5% 100%, pre-test-ESC ≤ 5% 98%, post-test-AHA/ACC ≤ 5% 98%, and post-test-ESC ≤ 5% 96%. Among participants, 26% had CACS = 0, 2% pre-test-AHA/ACC ≤ 5%, 7% pre-test-ESC ≤ 5%, 23% post-test-AHA/ACC ≤ 5%, and 33% post-test-ESC ≤ 5% (all P < 0.001). CONCLUSIONS: CACS and post-test probabilities are excellent predictors of abnormal perfusion and can rule it out with very high NPV in a substantial proportion of participants. CACS and post-test probabilities may be used as gatekeepers before advanced imaging. Coronary artery calcium score (CACS) predicted abnormal perfusion (SSS ≥ 4) in myocardial positron emission tomography (PET) better than pre-test probabilities of coronary artery disease (CAD), while pre-test-AHA/ACC and pre-test-ESC performed similarly (left). Using Bayes' formula, pre-test-AHA/ACC or pre-test-ESC were combined with CACS into post-test probabilities (middle). This calculation reclassified a substantial proportion of participants to low probability of CAD (0-5%), not needing further imaging, as shown for AHA/ACC probabilities (2% with pre-test-AHA/ACC to 23% with post-test-AHA/ACC, P < 0.001, right). Very few participants with abnormal perfusion were classified under pre-test or post-test probabilities 0-5%, or under CACS 0. AUC: area under the curve. Pre-test-AHA/ACC: Pre-test probability of the American Heart Association/American College of Cardiology. Post-test-AHA/ACC: Post-test probability combining pre-test-AHA/ACC and CACS. Pre-test-ESC: Pre-test probability of the European Society of Cardiology. SSS: Summed stress score.
引用
- Clerc OF, Frey SM, Honegger U, et al. Coronary artery calcium score and pre-test probabilities as gatekeepers to predict and rule out perfusion defects in positron emission tomography. J Nucl Cardiol. 2023. PMID: 37415007. doi:10.1007/s12350-023-03322-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。